Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
TETRAPHASE PHARMACEUTICALS INCListing unverified | Other | — | SEC | |
TETRAPHASE PHARMACEUTICALS INCListing unverified | Other | — | SEC | |
TALPHERA, INC.Listing on record | Other | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | Buy | $2.1M | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | Other | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | Other | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | Other | — | SEC | |
CONCERT PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | — | SEC | |
Targanta Therapeutics Corp.Listing unverified | Other | — | SEC | |
Targanta Therapeutics Corp.Listing unverified | Other | — | SEC | |
Targanta Therapeutics Corp.Listing unverified | Other | — | SEC |